🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Mayinglong Pharmaceutical Group Co., Ltd. (SHA:600993)
China flag China · Delayed Price · Currency is CNY
26.31
-0.12 (-0.45%)
Nov 20, 2026, 3:00 PM CST

SHA:600993 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
557.112,0883,0152,9882,4942,431
Short-Term Investments
116.980.45--138.81142.01
Trading Asset Securities
1,842506.09142.1463.29674.35106.02
Cash & Short-Term Investments
2,5162,5943,1573,0513,3072,679
Cash Growth
-5.00%-17.84%3.48%-7.72%23.45%15.22%
Accounts Receivable
713.75796.97457.05334.67409.64242.87
Other Receivables
16.1632.9136.5142.5744.9824.94
Receivables
729.91829.88493.56377.24454.62267.81
Inventory
301.2320.87277.63273.48336.2313.92
Other Current Assets
151.0462.3746.5369.48128.18100.85
Total Current Assets
3,6983,8073,9753,7724,2263,361
Property, Plant & Equipment
725.54735.98770.89635.53515.34440.44
Long-Term Investments
137.18570.9148.95152.83151.47176.79
Goodwill
22.9922.9925.2625.2625.2625.26
Other Intangible Assets
105.02114.0693.0990.1137.2836.9
Long-Term Deferred Tax Assets
56.354.5550.5949.4658.3621.63
Long-Term Deferred Charges
137.41119.97113.482.366.5258.44
Other Long-Term Assets
764.8310.414.622.468.146.27
Total Assets
5,6475,4365,1824,8305,0884,127

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
380.23318.2337.66289.69284.74156.82
Accrued Expenses
20.35161.969.53105.15118.5141.79
Short-Term Debt
-1131.845.888.188
Current Portion of Long-Term Debt
--107.799.79--
Current Portion of Leases
20.317.8118.4323.1228.1321.14
Finance Div. Other Current Liabilities
-22.2419.29---
Current Income Taxes Payable
136.4260.6567.236.2470.9860.42
Current Unearned Revenue
71.5499.7488.6591.86102.7588.18
Other Current Liabilities
166.1876.1164.0179.43164.94109.08
Total Current Liabilities
795.02767.64804.36681.07858.14665.44
Long-Term Debt
---100400-
Long-Term Leases
50.9970.3176.293.5912273.21
Long-Term Unearned Revenue
49.9955.4254.5627.8926.9529.03
Long-Term Deferred Tax Liabilities
22.7622.0923.528.6135.372.51
Other Long-Term Liabilities
5.856.0222.0428.4629.5442.53
Total Liabilities
924.62921.49980.66959.621,472812.72

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
431.05431.05431.05431.05431.05431.05
Additional Paid-In Capital
23.6223.4123.5351.51100.74105.2
Retained Earnings
4,1353,9233,6083,2532,9602,634
Comprehensive Income & Other
1.962.622.962.662.461.28
Total Common Equity
4,5924,3804,0663,7383,4953,171
Minority Interest
130.95135.01135.32131.94121.5142.82
Shareholders' Equity
4,7234,5154,2013,8703,6163,314
Total Liabilities & Equity
5,6475,4365,1824,8305,0884,127

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
71.2999.13234.22272.29638.23182.35
Net Cash (Debt)
2,4452,4952,9232,7792,6692,496
Net Cash Growth
-3.98%-14.64%5.19%4.14%6.90%13.90%
Net Cash Per Share
5.705.796.816.466.195.80
Filing Date Shares Outstanding
431.05431.05431.05431.05431.05431.05
Total Common Shares Outstanding
431.05431.05431.05431.05431.05431.05
Working Capital
2,9033,0403,1713,0913,3682,696
Book Value Per Share
10.6510.169.438.678.117.36
Tangible Book Value
4,4644,2433,9483,6233,4323,109
Tangible Book Value Per Share
10.369.849.168.407.967.21
Buildings
-617.08289.57290.61293.35290.37
Machinery
-467.86447.54401.77402.1292.67
Construction In Progress
-14.79357.6205.7425.718.75